Beam Therapeutics BEAM Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $288.29M-2.3% | $294.94M+10.1% | $267.96M-5.0% | $282.13M-46.6% | $527.91M+87.2% | ||
| $923.36M-2.8% | $950.27M+17.8% | $807.01M-7.0% | $868.21M+25.5% | $692.05M+21.7% | ||
| $6.69M+0.3% | $6.68M+0.3% | $6.66M+0.3% | $6.63M+0.3% | $6.61M-18.8% | ||
| $127.48M+27.7% | $99.84M-3.8% | $103.78M+3.8% | $99.98M+4.0% | $96.12M+0.5% | ||
| $1.27B-0.1% | $1.27B+15.5% | $1.1B-6.5% | $1.18B-5.8% | $1.25B+42.1% | ||
| $101.25M-3.1% | $104.5M-3.5% | $108.29M-0.5% | $108.82M-0.7% | $109.57M-1.7% | ||
| $98.15M-2.5% | $100.68M+3.8% | $97M-2.6% | $99.57M-2.6% | $102.22M-2.5% | ||
| $7.76M+1,124% | $634K+6.9% | $593K-11.2% | $668K-26.7% | $911K-27.4% | ||
| $1.48B0.0% | $1.48B+13.0% | $1.31B-5.8% | $1.39B-5.2% | $1.47B+32.9% | ||
| $42.62M+12.1% | $38.03M+20.1% | $31.67M+22.1% | $25.94M+30.9% | $19.81M+32.9% | ||
| $39.29M-28.9% | $55.27M+30.6% | $42.31M+3.4% | $40.9M+35.3% | $30.23M-36.3% | ||
| $304K-95.4% | $6.66M-94.0% | $110.32M+4.3% | $105.82M+24.2% | $85.2M-21.7% | ||
| $14.78M+2.9% | $14.36M+13.2% | $12.69M-2.0% | $12.95M-2.0% | $13.21M-1.9% | ||
| $74.57M-23.1% | $96.94M-46.9% | $182.56M+4.8% | $174.13M+23.0% | $141.55M-22.3% | ||
| —— | —— | —— | —— | —— | ||
| $135.85M-2.8% | $139.76M+0.7% | $138.73M-2.2% | $141.85M-2.1% | $144.92M-2.1% | ||
| —— | —— | —— | —— | —— | ||
| $305K+76.3% | $173K-35.0% | $266K-25.5% | $357K-13.8% | $414K-17.9% | ||
| $316.36M+30.3% | $242.82M-29.6% | $345.08M+0.2% | $344.34M+0.2% | $343.78M-7.2% | ||
| $1.03M+1.0% | $1.02M+0.3% | $1.01M+0.6% | $1.01M+0.2% | $1.01M+20.3% | ||
| $2.9B+0.8% | $2.88B+0.8% | $2.86B+1.1% | $2.82B+0.9% | $2.8B+21.7% | ||
| -$1.74B-5.7% | -$1.64B+13.2% | -$1.89B-6.3% | -$1.78B-6.1% | -$1.68B-7.0% | ||
| -$1.07M-196% | $1.11M+40.6% | $790K+7,800% | $10K-93.8% | $160K-76.4% | ||
| $1.16B-6.0% | $1.24B+28.2% | $966M-7.7% | $1.05B-7.3% | $1.13B+54.0% | ||
| $1.48B0.0% | $1.48B+13.0% | $1.31B-5.8% | $1.39B-5.2% | $1.47B+32.9% | ||
| $923.36M-2.8% | $950.27M+17.8% | $807.01M-7.0% | $868.21M+25.5% | $692.05M+21.7% | ||
| $7.76M+1,124% | $634K+6.9% | $593K-11.2% | $668K-26.7% | $911K-27.4% | ||
| $98.15M-2.5% | $100.68M+3.8% | $97M-2.6% | $99.57M-2.6% | $102.22M-2.5% | ||
| $98.15M-2.5% | $100.68M+3.8% | $97M-2.6% | $99.57M-2.6% | $102.22M-2.5% | ||
| $7.76M+1,124% | $634K+6.9% | $593K-11.2% | $668K-26.7% | $911K-27.4% | ||
| $98.15M-2.5% | $100.68M+3.8% | $97M-2.6% | $99.57M-2.6% | $102.22M-2.5% | ||
| $7.76M+1,124% | $634K+6.9% | $593K-11.2% | $668K-26.7% | $911K-27.4% | ||
| $5.2M-32.5% | $7.7M+18.5% | $6.5M+66.7% | $3.9M-25.0% | $5.2M-38.1% | ||
| $5.2M-32.5% | $7.7M+18.5% | $6.5M+66.7% | $3.9M-25.0% | $5.2M-38.1% | ||
| $5.45M-8.5% | $5.95M-11.3% | $6.71M+466% | $1.19M+2.4% | $1.16M+2.4% | ||
| $39.29M-28.9% | $55.27M+30.6% | $42.31M+3.4% | $40.9M+35.3% | $30.23M-36.3% | ||
| $250.82M+62.7% | $154.12M+1.8% | $151.42M-2.2% | $154.8M-2.1% | $158.13M-2.0% | ||
| $1.03M+1.0% | $1.02M+0.3% | $1.01M+0.6% | $1.01M+0.2% | $1.01M+20.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Beam Therapeutics cover its short-term obligations?
- Its current ratio is 16.99 — current assets exceed current liabilities.
- Where does Beam Therapeutics's balance sheet data come from?
- Every line is extracted from Beam Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.